Today the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan (USask) announced positive interim results from their Phase 1 clinical trial for COVAC-2, VIDO’s COVID-19 subunit vaccine candidate....
Impact Stories | Page 2
As variants of concern continue to drive COVID-19 transmission around the globe, researchers at Western’s Imaging Pathogens for Knowledge Translation (ImPaKT) Facility are shifting their work toward understanding how to target them....
Saskatchewan residents can give input about COVID-19 public health measures by using their smartphones to respond to a series of five-minute surveys....
Two out of three Vancouver physicians surveyed in a new UBC study faced burnout during the COVID-19 pandemic....
Professor Niayesh Afshordi used his knowledge of modeling the mysteries of the Cosmos to start modeling the mysteries of COVID-19....
McMaster researchers are leading a pan-Canadian study investigating the immune response to the COVID-19 vaccine within the South Asian community....
U of A researchers find SARS-CoV-2 infects immature red blood cells, reducing oxygen in the blood and impairing immune response....
Katarina Pessina began administering COVID-19 vaccines in March this year....
New tool uses AI technology to assess the severity of lung infections and inform treatment....